Fort LP’s Haemonetics HAE Stock Holding History

Fort LP’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-656	Closed	-$75K	–	416
2019 Q4	$75K	Buy	+656	New	+$79.4K	0.01%	377

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Fort LP's HAE Position: Q1 2020 in Review

Fort LP sold out of Haemonetics (HAE) in Q1 2020, closing a stake of 656 shares — an estimated $75K sold.

Fort LP first reported a position in HAE in Q4 2019 and held it in 1 quarter. The position peaked at $75K in Q4 2019. 269 funds tracked by Wall St. Rank hold HAE as of Q1 2020.

Fort LP reported no remaining Haemonetics position as of Q1 2020 after selling out during the quarter.
Fort LP sold 656 Haemonetics shares in Q1 2020, an estimated $75K.
Fort LP first reported a position in Haemonetics in Q4 2019 and held it in 1 quarter.
Fort LP's Haemonetics position peaked at $75K in Q4 2019.
269 funds tracked by Wall St. Rank held Haemonetics as of Q1 2020.

Based on Fort LP's 13F filing for Q1 2020, filed 14 May 2020.